Explore of Minimal clinically important differences (MCID) of the Scale for the Assessment and Rating of Ataxia (SARA) and the Vertigo Symptom Scale- short form (VSS-sf) in stroke. A multicenter prospective observational study.
Not Applicable
- Conditions
- Stroke
- Registration Number
- JPRN-UMIN000049620
- Lead Sponsor
- Sakurakai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
(1) before this stroke, modified Rankin Scale : mRS=>2 (2) Mini Mental State Examination-J (MMSE-J) <= 23 (3) dropout from rehabilitation program
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scale for the Assessment and Rating of Ataxia
- Secondary Outcome Measures
Name Time Method Vertigo Symptom Scale- short form
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with SARA MCID thresholds in ischemic stroke recovery?
How does VSS-sf MCID detection compare to vestibular evoked myogenic potential (VEMP) metrics in post-stroke vertigo?
What neuroimaging biomarkers predict SARA score improvement in cerebellar stroke subtypes?
Are there specific inflammatory markers associated with VSS-sf response in acute stroke populations?
How do SARA and VSS-sf MCID thresholds differ between anterior vs. posterior circulation stroke?